Demographics of Patients in Ultra-Low-Activity Group
| Variable | Dataset |
|---|---|
| Sex* | |
| Men | 20 |
| Women | 10 |
| Age (y)† | 66.1 ± 8.44 (48.00–77.00) |
| Height (cm)† | 165.5 ± 7.25 (157.00–186.20) |
| Weight (kg)† | 62.28 ± 10.2 (44.80–88.00) |
| BMI (kg/m2)† | 22.73 ± 3.28 (15.76–29.75) |
| Blood glucose (mmol/L)† | 5.75 ± 0.66 (4.80–7.00) |
| Uptake time (min)† | 60.97 ± 5.96 (51.00–70.00) |
| Injected dose (MBq)† | 25.53 ± 4.07 (17.76–33.67) |
| Primary tumor type* | |
| HCC and ICC | 4 |
| CRC | 11 |
| Lung cancer | 1 |
| Pancreatic cancer | 3 |
| Esophageal cancer | 2 |
| Mediastinal sarcoma | 1 |
| Bladder cancer | 4 |
| Ovarian cancer | 2 |
| Lymphoma | 1 |
| Laryngeal cancer | 1 |
* Number of patients.
↵†Data are presented as mean ± SD followed by range in parentheses.
BMI = body mass index; HCC = hepatocellular carcinoma; ICC = intrahepatic cholangiocarcinoma.